Mary Clare Fraser - 02 Jun 2026 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: SVP & Chief HRO
Issuer ticker: STE
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:32:52 UTC
Prior SEC filing: 03 Jun 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Mary Clare Fraser filed Form 4 for STERIS plc (STE) on 04 Jun 2026.

Key facts

This page summarizes Mary Clare Fraser's Form 4 filing for STERIS plc (STE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 16:32.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001818882 Primary reporting owner

Fraser Mary Clare

Relationship: SVP & Chief HRO
Address: 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Award

Transaction value
Shares: +3,009
Change %: +25%
Price: $0.000000^*
Shares after: 15,218
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

STE transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -591
Change %: -3.9%
Price: $209.76^*
Shares after: 14,627
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +10,492
Change %
Price: $0.000000^*
Shares after: 10,492
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 10,492
Exercise price: $230.74
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

As of June 2, 2026, 7,554 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 835 on June 3, 2026; 1,360 on June 4, 2026; 1,003 on June 2, 2027; 835 on June 3, 2027; 680 on June 4, 2027; 1,003 on June 2, 2028; 835 on June 5, 2028 and 1,003 on June 4, 2029.

Footnote F2

591 shares were withheld from the 2,028 restricted shares that vested on June 2, 2026. These 591 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.

Footnote F3

This option becomes exercisable as follows: 2,623 on June 2, 2027, 2,623 on June 2, 2028, 2,623 on June 4, 2029 and 2,623 on June 3, 2030.